Polyphenols isolated from Broussonetia kazinoki prevent cytokine-induced β-cell damage and the development of type 1 diabetes

Experimental and Molecular Medicine

Volumn 47, Issue 4, 2015, Pages

  Bae, Ui Jin ^a   Jang, Hyun Young ^a   Lim, Jung Min ^a   Hua, Li ^b   Ryu, Jae Ha ^b   Park, Byung Hyun ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Sookmyung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HEMITERPENE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KAZINOL C; NITRIC OXIDE; RESORCINOL DERIVATIVE;

ANIMAL; APOPTOSIS; BROUSSONETIA; C57BL MOUSE; CELL CULTURE; CELL LINE; CHEMISTRY; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MOUSE; PANCREAS ISLET BETA CELL; PATHOLOGY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BROUSSONETIA; CELL LINE; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 1; HEMITERPENES; INSULIN-SECRETING CELLS; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; NITRIC OXIDE; RATS; RESORCINOLS; SIGNAL TRANSDUCTION;

EID: 85018215069     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/EMM.2015.16     Document Type: Article

References (34)

1. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37(Suppl 1): S81–S90.
2. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005; 54(Suppl 2): S97–S107.
3. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and β-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009; 5: 219–226.
4. Lukic ML, Stosic-Grujicic S, Shahin A. Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev Immunol 1998; 6: 119–128.
5. Flodstrom M, Tyrberg B, Eizirik DL, Sandler S. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 1999; 48: 706–713.
6. Mabley JG, Hasko G, Liaudet L, Soriano FG, Southan GJ, Salzman AL et al. NFκB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J Endocrinol 2002; 173: 457–464.
7. Kim EK, Kwon KB, Song MY, Han MJ, Lee JH, Lee YR et al. Flavonoids protect against cytokine-induced pancreatic β-cell damage through suppression of nuclear factor κB activation. Pancreas 2007; 35: e1–e9.
8. Kim EK, Kwon KB, Song MY, Seo SW, Park SJ, Ka SO et al. Genistein protects pancreatic β cells against cytokine-mediated toxicity. Mol Cell Endocrinol 2007; 278: 18–28.
9. Lee SM, Yang H, Tartar DM, Gao B, Luo X, Ye SQ et al. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia 2011; 54: 1136–1146.
10. Song MY, Jeong GS, Kwon KB, Ka SO, Jang HY, Park JW et al. Sulfuretin protects against cytokine-induced β-cell damage and prevents streptozotocin-induced diabetes. Exp Mol Med 2010; 42: 628–638.
11. Song MY, Kim EK, Moon WS, Park JW, Kim HJ, So HS et al. Sulforaphane protects against cytokine-and streptozotocin-induced β-cell damage by sup-pressing the NF-κB pathway. Toxicol Appl Pharmacol 2009; 235: 57–67.
12. Chen RM, Hu LH, An TY, Li J, Shen Q. Natural PTP1B inhibitors from Broussonetia papyrifera. Bioorg Med Chem Lett 2002; 12: 3387–3390.
13. Ryu HW, Lee BW, Curtis-Long MJ, Jung S, Ryu YB, Lee WS et al. Polyphenols from Broussonetia papyrifera displaying potent α-glucosidase inhibition. J Agric Food Chem 2010; 58: 202–208.
14. Kim AY, Lee CG, Lee da Y, Li H, Jeon R, Ryu JH et al. Enhanced antioxidant effect of prenylated polyphenols as Fyn inhibitor. Free Radic Biol Med 2012; 53: 1198–1208.
15. Bae UJ, Lee da Y, Song MY, Lee SM, Park JW, Ryu JH et al. A prenylated flavan from Broussonetia kazinoki prevents cytokine-induced β-cell death through suppression of nuclear factor-κB activity.Biol Pharm Bull 2011; 34: 1026–1031.
16. Bae UJ, Song MY, Jang HY, Gim HJ, Ryu JH, Lee SM et al. The efficacy of SPA0355 in protecting β cells in isolated pancreatic islets and in a murine experimental model of type 1 diabetes. Exp Mol Med 2013; 45: e51.
17. Song MY, Bae UJ, Jang KY, Park BH. Transplantation of betacellulin-transduced islets improves glucose intolerance in diabetic mice. Exp Mol Med 2014; 46: e98.
18. Su D, Zhang N, He J, Qu S, Slusher S, Bottino R et al. Angiopoietin-1 production in islets improves islet engraftment and protects islets from cytokine-induced apoptosis. Diabetes 2007; 56: 2274–2283.
19. Ho E, Chen G, Bray TM. Supplementation of N-acetylcysteine inhibits NFκB activation and protects against alloxan-induced diabetes in CD-1 mice. FASEB J 1999; 13: 1845–1854.
20. Baek YS, Ryu YB, Curtis-Long MJ, Ha TJ, Rengasamy R, Yang MS et al. Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki. Bioorg Med Chem 2009; 17: 35–41.
21. Zhang PC, Wang S, Wu Y, Chen RY, Yu DQ. Five new diprenylated flavonols from the leaves of Broussonetia kazinoki. J Nat Prod 2001; 64: 1206–1209.
22. Ryu JH, Ahn H, Jin Lee H. Inhibition of nitric oxide production on LPS-activated macrophages by kazinol B from Broussonetia kazinoki. Fitoterapia 2003; 74: 350–354.
23. Cha JY, Kim YT, Kim HS, Cho YS. Antihyperglycemic effect of stem bark powder from paper mulberry (Broussonetia kazinoki Sieb.) in type 2 diabetic Otsuka Long-Evans Tokushima fatty rats. JMedFood2008; 11: 499–505.
24. Eldor R, Yeffet A, Baum K, Doviner V, Amar D, Ben-Neriah Y et al. Conditional and specific NF-κB blockade protects pancreatic β cells from diabetogenic agents. Proc Natl Acad Sci USA 2006; 103: 5072–5077.
25. Ortis F, Pirot P, Naamane N, Kreins AY, Rasschaert J, Moore F et al. Induction of nuclear factor-κB and its downstream genes by TNF-α and IL-1β has a pro-apoptotic role in pancreatic β cells. Diabetologia 2008; 51: 1213–1225.
26. Hagerkvist R, Sandler S, Mokhtari D, Welsh N. Amelioration of diabetes by imatinib mesylate (Gleevec): role of β-cell NF-κB activation and anti-apoptotic preconditioning. FASEB J 2007; 21: 618–628.
27. Kim S, Millet I, Kim HS, Kim JY, Han MS, Lee MK et al. NF-κB prevents β cell death and autoimmune diabetes in NOD mice. Proc Natl Acad Sci USA 2007; 104: 1913–1918.
28. Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL. IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 2003; 46: 255–266.
29. Mokhtari D, Barbu A, Mehmeti I, Vercamer C, Welsh N. Overexpression of the nuclear factor-κB subunit c-Rel protects against human islet cell death in vitro. Am J Physiol Endocrinol Metab 2009; 297: E1067–E1077.
30. Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M et al. Inhibition of cytokine-induced NF-κB activation by adenovirus-mediated expression of a NF-κB super-repressor prevents β-cell apoptosis. Diabetes 2001; 50: 2219–2224.
31. Lewis EC, Blaabjerg L, Storling J, Ronn SG, Mascagni P, Dinarello CA et al. The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro. Mol Med 2011; 17: 369–377.
32. Szabo C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007; 6: 662–680.
33. Broniowska KA, Mathews CE, Corbett JA. Do β-cells generate peroxynitrite in response to cytokine treatment? J Biol Chem 2013; 288: 36567–36578.
34. Rink JS, Chen X, Zhang X, Kaufman DB. Conditional and specific inhibition of NF-κB in mouse pancreatic β cells prevents cytokine-induced deleterious effects and improves islet survival posttransplant. Surgery 2012; 151: 330–339.